310 related articles for article (PubMed ID: 21266573)
1. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism.
Caccamo A; Maldonado MA; Majumder S; Medina DX; Holbein W; Magrí A; Oddo S
J Biol Chem; 2011 Mar; 286(11):8924-32. PubMed ID: 21266573
[TBL] [Abstract][Full Text] [Related]
2. Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease.
Velazquez R; Shaw DM; Caccamo A; Oddo S
Mol Neurodegener; 2016 Jul; 11(1):52. PubMed ID: 27412291
[TBL] [Abstract][Full Text] [Related]
3. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
Caccamo A; Belfiore R; Oddo S
Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
Wang C; Zhang X; Teng Z; Zhang T; Li Y
Eur J Pharmacol; 2014 Oct; 740():312-20. PubMed ID: 25041840
[TBL] [Abstract][Full Text] [Related]
5. Parkin prevents cortical atrophy and Aβ-induced alterations of brain metabolism: ¹³C NMR and magnetic resonance imaging studies in AD models.
Algarzae N; Hebron M; Miessau M; Moussa CE
Neuroscience; 2012 Dec; 225():22-34. PubMed ID: 22960314
[TBL] [Abstract][Full Text] [Related]
6. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.
Caccamo A; De Pinto V; Messina A; Branca C; Oddo S
J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720
[TBL] [Abstract][Full Text] [Related]
7. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
[TBL] [Abstract][Full Text] [Related]
8. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice.
Li X; Zhang H; Yang L; Dong X; Han Y; Su Y; Li W; Li W
Behav Brain Funct; 2023 Apr; 19(1):7. PubMed ID: 37055801
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
[TBL] [Abstract][Full Text] [Related]
11. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.
Caccamo A; Majumder S; Richardson A; Strong R; Oddo S
J Biol Chem; 2010 Apr; 285(17):13107-20. PubMed ID: 20178983
[TBL] [Abstract][Full Text] [Related]
12. PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling.
Yang W; Yang LF; Song ZQ; Shah SZA; Cui YY; Li CS; Zhao HF; Gao HL; Zhou XM; Zhao DM
CNS Neurosci Ther; 2017 May; 23(5):416-427. PubMed ID: 28294542
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
Chen J; Long Z; Li Y; Luo M; Luo S; He G
Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
[TBL] [Abstract][Full Text] [Related]
14. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
[TBL] [Abstract][Full Text] [Related]
15. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
[TBL] [Abstract][Full Text] [Related]
16. Akt activation ameliorates deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an Alzheimer's disease mouse model.
Kommaddi RP; Gowaikar R; P A H; Diwakar L; Singh K; Mondal A
J Biol Chem; 2024 Feb; 300(2):105619. PubMed ID: 38182004
[TBL] [Abstract][Full Text] [Related]
17. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease.
Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ
Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821
[TBL] [Abstract][Full Text] [Related]
18. PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection.
Chong ZZ; Shang YC; Wang S; Maiese K
PLoS One; 2012; 7(9):e45456. PubMed ID: 23029019
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.
Ma T; Hoeffer CA; Capetillo-Zarate E; Yu F; Wong H; Lin MT; Tampellini D; Klann E; Blitzer RD; Gouras GK
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862226
[TBL] [Abstract][Full Text] [Related]
20. [Effect of mammalian target of rapamycin on cognitive dysfunction of Alzheimer's Disease via regulating Homer3].
Huang YQ; Liu XG; Zhang L; Yu Y; Xue J; Sun JL
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1336-1340. PubMed ID: 32375443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
